Clinical Trial Update: Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized double-blind trial evaluating convalescent plasma for SARS-related pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars Pneumonia

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Grupo Mexicano para el Estudio de la Medicina Intensiva | Conditions: SARS Pneumonia | Phase 2 | Status: COMPLETED